Do not inject a double dose to make up for a missed one
Response to letter regarding article, Heart failure, saxagliptin and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial
Disclosures: Himsikhar Khataniar: Nothing to Disclose, Aakash Desai: Nothing to Disclose, Muhammad Ali Butt: Nothing to Disclose, Michael Babich: Abbvie: Speaking and Teaching, Gilead pharma: Speaking and Teaching, Salix pharma: Speaking and Teaching, Intercept pharma: Speaking and Teaching, Madrigal pharma: Speaking and Teaching, Nabeeha Mohy-ud-din: Nothing to Disclose 1593 HEPATOCYTE-SPECIFIC DELETION OF BETAINE HOMOCYSTEINE METHYLTRANSFERASE PROMOTES ALCOHOL-INDUCED LIVER INJURY Ramachandran Rajamanickam 1 Sathish kumar Perumal 1 Poonam Sagar 1 Natalia Osna 1 Karuna Rasineni 1 Kusum Kharbanda 2 , 1 University of Nebraska Medical Center, 2 Department of Veterans Affairs, Veterans Affairs Nebraska-Western Iowa Health Care System Background: Alcohol- associated liver disease (ALD) remains a significant health concern globally
25,26 Both trials are completed but are not yet published
